Get startedLog in
    Picture of BioArctic AB logo

    BIOA B — BioArctic AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: FDA Grants Traditional Approval For Leqembi® (Lecanemab-Irmb) For The Treatment Of Alzheimer's Disease

    Picture of BioArctic AB logoBioArctic AB
    07/07/2023 04:00
    July 6 (Reuters) - BioArctic AB  BIOAb.ST :
    * FDA GRANTS TRADITIONAL APPROVAL FOR LEQEMBI®
(LECANEMAB-IRMB)
FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Source text for Eikon:  ID:nPnbbBclza 
Further company coverage:  BIOAb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on BioArctic AB

    See all news